908 Devices Inc. (MASS)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, 908 Devices Inc. currently loses $74.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 9
in 15 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
908 Devices’ second fiscal quarter of 2026 paired a revenue beat with an EPS miss, as revenue of $16.1 million topped the $15.4 million estimate (+4.6%) while EPS of -$0.32 trailed the -$0.14 estimate by -$0.18; the company reported these results on August 11, 2026. Revenue rose ~23% to about $16.1 million (up from roughly $13.0 million a year ago), supported by its handheld analytical instruments portfolio that includes MX908 and XplorIR. Gross profit came in at about $8.3 million, with gross margin at roughly 52%, while operating income was -about $12.8 million and operating margin was near -80%. Net income was -roughly $11.9 million, improving ~11% from about -$13.3 million a year ago, and EPS improved ~11% from -$0.36. The quarter generated operating cash flow of about $3.2 million. Next-period consensus calls for EPS of -$0.16 on revenue of $18.3 million.
Next report — what to expect
908 Devices Inc. (MASS) reports earnings on November 9, 2026. Wall Street is looking for EPS of -$0.16 on revenue of $18.3 million. For trailing context, revenue grew +23.3% year over year last quarter. The company has beaten EPS in 3 of 8 most recent quarters.
About 908 Devices Inc.
908 Devices Inc. develops handheld analytical instruments for health and safety work, selling on-device mass spectrometry and infrared-based detection systems used to identify unknown substances, gases, vapors, and chemical hazards. The company trades on NASDAQ as MASS in the medical technology field, and generated $56.2 million of revenue in FY2025.
Today's Snapshot
MASS closed 1.2% higher at 11.49, outperforming a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level.
Trading Volume
Below 10d avg (333.1K)
208.2K
vs S&P 500 Today
Outperforming Market
+1.75%
Updated: October 23, 2026 at 20:11 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$8.66 - $11.62Buy
- RSI (14)50.49Neutral
- Stochastic %K (14, 3, 3)19.14Buy
- MACD Level (12, 26)0.16Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.